-
Over 700 people a year could benefit from a new potentially life-extending lung cancer drug which targets a specific genetic mutation
New potentially life-extending lung cancer drug which targets a specific genetic mutation recommended by NICE
-
NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance.
Two new antimicrobial drugs - cefiderocol and ceftazidime–avibactam - are close to becoming the first to be made available as part of the UK’s innovative subscription-style payment model after NICE today (Tuesday, 12 April 2022) published draft guidance estimating their value to the NHS.
-
Keep the size of your waist to less than half of your height, updated NICE draft guideline recommends
Keep the size of your waist to less than half of your height, updated NICE draft guideline recommends
-
NICE says new triple negative advanced breast cancer drug too expensive for NHS use
NICE has today, 7 April 2022, issued draft guidance which does not recommend sacituzumab govitecan for treating locally advanced or metastatic triple negative breast cancer.
-
Hundreds of people with some forms of urothelial cancer to receive new treatment
Over 800 people with locally advanced or metastatic urothelial cancer are set to benefit from a new treatment – avelumab – following its recommendation for routine NHS funding in final draft guidance published today (Thursday 7 April) by NICE.
-
Thousands of people set to benefit from first new treatment for osteoporosis for over a decade
Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab – after NICE recommended it for people after menopause in final draft guidance published today (Friday 1 April) by NICE.
-
Thousands of people with diabetes set to benefit from real time information after updated NICE recommendations
More than 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their condition and at the same time reduce the need for finger prick testing by up to 50%, following new advice from NICE.
-
NICE calls for further research into the treatment of chronic lipoedema
NICE has today issued interventional procedures guidance on the use of liposuction for the treatment of chronic lipoedema.
-
Pregnant women to be offered first test to help diagnose pre-eclampsia
Midwives caring for pregnant women can use one of four blood tests to help diagnose suspected preterm pre-eclampsia, NICE has said in new draft diagnostic guidance.